IMMUNOHISTOCHEMISTRY CD34 Test
Welcome to DNA Labs UAE, where we offer the IMMUNOHISTOCHEMISTRY CD34 test for cancer diagnosis. This test helps detect the presence of CD34 protein in tissue samples, aiding in the differentiation of different types of tumors and determining the origin of metastatic tumors.
Test Details
The CD34 test is an immunohistochemistry (IHC) test used to detect the presence of CD34 protein in tissue samples. CD34 is a transmembrane glycoprotein primarily expressed on hematopoietic stem cells and vascular endothelial cells.
The CD34 test is commonly used in pathology to differentiate between different types of tumors and to determine the origin of metastatic tumors. It can help identify tumors derived from hematopoietic cells, such as lymphomas and leukemias, as well as tumors originating from vascular endothelial cells, such as angiosarcomas.
During the CD34 test, a tissue sample is obtained, typically through a biopsy or surgical resection. The sample is then processed and embedded in paraffin, and thin sections are cut onto glass slides. These sections are then treated with specific antibodies against CD34, which bind to the CD34 protein if it is present in the tissue.
After incubation with the primary antibody, the sections are washed to remove any unbound antibody. A secondary antibody is then applied, which is conjugated to a detection system, such as an enzyme or fluorescent molecule. This secondary antibody binds to the primary antibody, allowing for visualization of the CD34 protein.
The stained tissue sections are then examined under a microscope, and the presence and distribution of CD34 protein are assessed. Positive staining indicates the presence of CD34 protein in the tissue, while negative staining suggests its absence.
The CD34 test is an important tool in the diagnosis and classification of various tumors. It can help guide treatment decisions and provide valuable information about the prognosis of patients.
Test Cost and Sample Condition
The cost of the IMMUNOHISTOCHEMISTRY CD34 test is AED 410.0. To perform the test, please submit tumor tissue in 10% Formal-saline or a Formalin fixed paraffin embedded block. The sample should be shipped at room temperature.
Please provide a copy of the Histopathology report, the site of biopsy, and the patient’s clinical history along with the sample.
Report Delivery
Sample results are delivered daily by 6 pm. The report block takes 5 days, while tissue biopsy and tissue large complex results take 5 and 7 days, respectively.
Test Type and Doctor
The IMMUNOHISTOCHEMISTRY CD34 test is specifically designed for cancer diagnosis. It is performed by our experienced oncologists and pathologists.
Pre Test Information
Please provide a copy of the Histopathology report, the site of biopsy, and the patient’s clinical history before performing the CD34 test.
At DNA Labs UAE, we are committed to providing accurate and reliable test results to aid in the diagnosis and treatment of cancer. Contact us today to schedule your IMMUNOHISTOCHEMISTRY CD34 test.
| Test Name | IMMUNOHISTOCHEMISTRY CD34 Test |
|---|---|
| Components | |
| Price | 410.0 AED |
| Sample Condition | Submit tumor tissue in 10% Formal-saline OR Formalin fixed paraffin embedded block. Ship at room temperature. Provide a copy of the Histopathology report, Site of biopsy and Clinical history. |
| Report Delivery | Sample Daily by 6 pm; Report Block: 5 days Tissue Biopsy: 5 days Tissue large complex : 7 days |
| Method | Immunohistochemistry |
| Test type | Cancer |
| Doctor | Oncologist, Pathologist |
| Test Department: | |
| Pre Test Information | Provide a copy of the Histopathology report, Site of biopsy and Clinical history. |
| Test Details |
The CD34 test is an immunohistochemistry (IHC) test used to detect the presence of CD34 protein in tissue samples. CD34 is a transmembrane glycoprotein that is primarily expressed on hematopoietic stem cells and vascular endothelial cells. The CD34 test is commonly used in pathology to differentiate between different types of tumors and to determine the origin of metastatic tumors. It can help identify tumors derived from hematopoietic cells, such as lymphomas and leukemias, as well as tumors originating from vascular endothelial cells, such as angiosarcomas. During the CD34 test, a tissue sample is obtained, typically through a biopsy or surgical resection. The sample is then processed and embedded in paraffin, and thin sections are cut onto glass slides. These sections are then treated with specific antibodies against CD34, which bind to the CD34 protein if it is present in the tissue. After incubation with the primary antibody, the sections are washed to remove any unbound antibody. A secondary antibody is then applied, which is conjugated to a detection system, such as an enzyme or fluorescent molecule. This secondary antibody binds to the primary antibody, allowing for visualization of the CD34 protein. The stained tissue sections are then examined under a microscope, and the presence and distribution of CD34 protein are assessed. Positive staining indicates the presence of CD34 protein in the tissue, while negative staining suggests its absence. The CD34 test is an important tool in the diagnosis and classification of various tumors. It can help guide treatment decisions and provide valuable information about the prognosis of patients. |
